How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Public Health Archives

Early Release – Microbial Etiology of Postoperative Spinal Fusion Infections and Factors Associated with Gram-Negative Infections, United States, 2021–2022 – Volume 32, Number 11—November 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

October 14, 2026 No Comments

Early Release – Choral Voices, Communal Vulnerability – Volume 32, Number 11—November 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

October 14, 2026 No Comments

Twenty-one countries launch coordinated Andes virus research initiative following hantavirus outbreak

Following the recent Andes virus (ANDV) outbreak linked to the MV Hondius cruise ship, a

October 14, 2026 No Comments

Early Release – Evidence of Exposure to Highly Pathogenic Avian Influenza H5 Viruses in East Greenland Polar Bears – Volume 32, Number 11—November 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

October 13, 2026 No Comments

People Say These Peptides Hurt Them. Their Stories Are Muffled in MAHA’s Push for Medical Freedom.

After the third day of squirting an experimental drug up his nose, Dylan Meetze felt

October 13, 2026 No Comments

Catherine Houlihan: A Cruise Ship Outbreak Exposed the Real Gap in Our Pandemic Defenses — Nobody Knows How to Stop the Virus Before Symptoms

In April 2026, a couple boarded the MV Hondius, a Dutch expedition cruise ship, in

October 13, 2026 No Comments

Early Release – Choral Voices, Communal Vulnerability – Volume 32, Number 11—November 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

October 13, 2026 No Comments

Early Release – Evidence of Exposure to Highly Pathogenic Avian Influenza H5 Viruses in East Greenland Polar Bears – Volume 32, Number 11—November 2026 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected

October 13, 2026 No Comments

‘Medicare for All’ Is Back. Now Comes the Hard Part.

As Americans grow increasingly frustrated with their healthcare system, a proposal that has long been

October 12, 2026 No Comments

AI, Tech Leaders Are Lobbying Trump Health Officials in a Government-Run Chat Room

A cadre of elite techies, financiers, and high-level Trump administration officials have spent a year

October 11, 2026 No Comments

Early Release – Microbial Etiology of Postoperative Spinal Fusion Infections and Factors Associated with Gram-Negative Infections, United States, 2021–2022 – Volume 32, Number 11—November 2026 – Emerging Infectious Diseases journal

Early Release – Choral Voices, Communal Vulnerability – Volume 32, Number 11—November 2026 – Emerging Infectious Diseases journal

Twenty-one countries launch coordinated Andes virus research initiative following hantavirus outbreak

Early Release – Evidence of Exposure to Highly Pathogenic Avian Influenza H5 Viruses in East Greenland Polar Bears – Volume 32, Number 11—November 2026 – Emerging Infectious Diseases journal

People Say These Peptides Hurt Them. Their Stories Are Muffled in MAHA’s Push for Medical Freedom.

Catherine Houlihan: A Cruise Ship Outbreak Exposed the Real Gap in Our Pandemic Defenses — Nobody Knows How to Stop the Virus Before Symptoms

Early Release – Choral Voices, Communal Vulnerability – Volume 32, Number 11—November 2026 – Emerging Infectious Diseases journal

Early Release – Evidence of Exposure to Highly Pathogenic Avian Influenza H5 Viruses in East Greenland Polar Bears – Volume 32, Number 11—November 2026 – Emerging Infectious Diseases journal

‘Medicare for All’ Is Back. Now Comes the Hard Part.

AI, Tech Leaders Are Lobbying Trump Health Officials in a Government-Run Chat Room

Schedule an Appointment

Quick Links

Patient Forms

Contact Us